163 related articles for article (PubMed ID: 29198863)
1. Synthesis, antitumor activity, and cytotoxicity of 4-substituted 1-benzyl-5-diphenylstibano-1H-1,2,3-triazoles.
Yamada M; Takahashi T; Hasegawa M; Matsumura M; Ono K; Fujimoto R; Kitamura Y; Murata Y; Kakusawa N; Tanaka M; Obata T; Fujiwara Y; Yasuike S
Bioorg Med Chem Lett; 2018 Jan; 28(2):152-154. PubMed ID: 29198863
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel 1,2,4-triazoles, triazolothiadiazines and triazolothiadiazoles as potential anticancer agents.
Kamel MM; Megally Abdo NY
Eur J Med Chem; 2014 Oct; 86():75-80. PubMed ID: 25147148
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro pharmacological evaluation of N-[(1-benzyl-1,2,3-triazol-4-yl)methyl]-carboxamides on d-secoestrone scaffolds.
Szabó J; Bacsa I; Wölfling J; Schneider G; Zupkó I; Varga M; Herman BE; Kalmár L; Szécsi M; Mernyák E
J Enzyme Inhib Med Chem; 2016 Aug; 31(4):574-9. PubMed ID: 26360618
[TBL] [Abstract][Full Text] [Related]
4. A Novel Series of N-aryltriazole and N-acridinyltriazole Hybrids as Potential Anticancer Agents.
Rono CK; Darkwa J; Meyer D; Makhubela BCE
Curr Org Synth; 2019; 16(6):900-912. PubMed ID: 31984911
[TBL] [Abstract][Full Text] [Related]
5. A Novel Method to Synthesize 4-Aryl-1H-1,2,3-Triazoles and its Antihepatoma Activity.
Li X; He Y; Hai L; Zhang T; Wu Y
Anticancer Agents Med Chem; 2016; 16(12):1622-1627. PubMed ID: 26592747
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, Molecular Docking Study and in vitro Anticancer Activity of Tetrazole Linked Benzochromene Derivatives.
Gorle S; Maddila S; Maddila SN; Naicker K; Singh M; Singh P; Jonnalagadda SB
Anticancer Agents Med Chem; 2017; 17(3):464-470. PubMed ID: 27357544
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, antitumor activity evaluation and mechanistic study of novel hederacolchiside A
Li HN; Wang H; Wang ZP; Yan HN; Zhang M; Liu Y; Cheng MS
Bioorg Med Chem; 2018 Aug; 26(14):4025-4033. PubMed ID: 29958763
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of N-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)nicotinamides as potential anticancer agents that inhibit tubulin polymerization.
Kamal A; Reddy NV; Nayak VL; Bolla NR; Subba Rao AV; Prasad B
Bioorg Med Chem; 2014 Jul; 22(13):3465-77. PubMed ID: 24835786
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of antitumour (1H-1,2,3-triazol-4-yl)-4-hydroxycyclohexa-2,5-dien-1-ones by copper-catalysed Huisgen cycloadditions.
McCarroll AJ; Matthews CS; Wells G; Bradshaw TD; Stevens MF
Org Biomol Chem; 2010 May; 8(9):2078-84. PubMed ID: 20401384
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and antiproliferative activity of functionalized flavone-triazole-tetrahydropyran conjugates against human cancer cell lines.
Ahmed N; Konduru NK; Ahmad S; Owais M
Eur J Med Chem; 2014 Jul; 82():552-64. PubMed ID: 24941129
[TBL] [Abstract][Full Text] [Related]
11. Stereocontrolled synthesis of the four possible 3-methoxy and 3-benzyloxy-16-triazolyl-methyl-estra-17-ol hybrids and their antiproliferative activities.
Kiss A; Wölfling J; Mernyák E; Frank É; Benke Z; Ashkan Senobar Tahaei S; Zupkó I; Mahó S; Schneider G
Steroids; 2019 Dec; 152():108500. PubMed ID: 31536732
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents.
Duan YC; Ma YC; Zhang E; Shi XJ; Wang MM; Ye XW; Liu HM
Eur J Med Chem; 2013 Apr; 62():11-9. PubMed ID: 23353743
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 3-hydroxymethyl-5-(1H-1,2,3-triazol) isoxazolidines.
Romeo R; Giofrè SV; Carnovale C; Campisi A; Parenti R; Bandini L; Chiacchio MA
Bioorg Med Chem; 2013 Dec; 21(24):7929-37. PubMed ID: 24436994
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel 1H-1,2,3-triazole tethered C-5 substituted uracil-isatin conjugates and their cytotoxic evaluation.
Kumar K; Sagar S; Esau L; Kaur M; Kumar V
Eur J Med Chem; 2012 Dec; 58():153-9. PubMed ID: 23124212
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of novel 1,2,3-triazole derivatives of coronopilin as anti-cancer compounds.
Khazir J; Hyder I; Gayatri JL; Prasad Yandrati L; Nalla N; Chasoo G; Mahajan A; Saxena AK; Alam MS; Qazi GN; Sampath Kumar HM
Eur J Med Chem; 2014 Jul; 82():255-62. PubMed ID: 24910974
[TBL] [Abstract][Full Text] [Related]
16. Spirooxindole-derived morpholine-fused-1,2,3-triazoles: Design, synthesis, cytotoxicity and apoptosis inducing studies.
Senwar KR; Sharma P; Reddy TS; Jeengar MK; Nayak VL; Naidu VG; Kamal A; Shankaraiah N
Eur J Med Chem; 2015 Sep; 102():413-24. PubMed ID: 26301558
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological testing of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxin analogues as antitumor agents.
Reddy PB; Paul DV; Agrawal SK; Saxena AK; Kumar HM; Qazi GN
Arch Pharm (Weinheim); 2008 Feb; 341(2):126-31. PubMed ID: 18214838
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and cytotoxic evaluation of novel indenoisoquinoline-substituted triazole hybrids.
Pham Thi T; Le Nhat TG; Ngo Hanh T; Luc Quang T; Pham The C; Dang Thi TA; Nguyen HT; Nguyen TH; Hoang Thi P; Van Nguyen T
Bioorg Med Chem Lett; 2016 Aug; 26(15):3652-7. PubMed ID: 27342752
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and preliminary anticancer activity of new 1,4-dihydro-3-(3-hydroxy-2-naphthyl)-4-substituted-5H-1,2,4-triazoline-5-thiones.
Duran A; Dogan HN; Rollas S
Farmaco; 2002 Jul; 57(7):559-64. PubMed ID: 12164214
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiproliferative evaluation of 3,5-disubstituted 1,2,4-triazoles containing flurophenyl and trifluoromethanephenyl moieties.
Wang LY; Tseng WC; Wu TS; Kaneko K; Takayama H; Kimura M; Yang WC; Wu JB; Juang SH; Wong FF
Bioorg Med Chem Lett; 2011 Sep; 21(18):5358-62. PubMed ID: 21802949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
